Global Biopharmaceutical Contract Manufacturing Market Research Report 2023

The global Biopharmaceutical Contract Manufacturing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Biopharmaceutical Contract Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Biopharmaceutical Contract Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Biopharmaceutical Contract Manufacturing in Autoimmune Diseases is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Biopharmaceutical Contract Manufacturing include Lonza Group, Baxter Biopharma Solutions, Samsung, Fujifilm Diosynth Biotechnologies, Boehringer Ingelheim, Patheon, Rentschler Biotechnologie, Biomeva and Probiogen, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Contract Manufacturing.

The Biopharmaceutical Contract Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biopharmaceutical Contract Manufacturing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biopharmaceutical Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Growth Factors

1.2.3 Interferons

1.2.4 Monoclonal Antibodies

1.2.5 Recombinant Hormones

1.2.6 Vaccines

1.2.7 Insulin

1.2.8 Others

1.3 Market by Application

1.3.1 Global Biopharmaceutical Contract Manufacturing Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Autoimmune Diseases

1.3.3 Oncology

1.3.4 Metabolic Diseases

1.3.5 Ophthalmology

1.3.6 Cardiovascular Diseases

1.3.7 Infectious Diseases

1.3.8 Neurology

1.3.9 Respiratory Disorders

1.3.10 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Biopharmaceutical Contract Manufacturing Market Perspective (2018-2029)

2.2 Biopharmaceutical Contract Manufacturing Growth Trends by Region

2.2.1 Global Biopharmaceutical Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Biopharmaceutical Contract Manufacturing Historic Market Size by Region (2018-2023)

2.2.3 Biopharmaceutical Contract Manufacturing Forecasted Market Size by Region (2024-2029)

2.3 Biopharmaceutical Contract Manufacturing Market Dynamics

2.3.1 Biopharmaceutical Contract Manufacturing Industry Trends

2.3.2 Biopharmaceutical Contract Manufacturing Market Drivers

2.3.3 Biopharmaceutical Contract Manufacturing Market Challenges

2.3.4 Biopharmaceutical Contract Manufacturing Market Restraints

3.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue

3.1.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue (2018-2023)

3.1.2 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Players (2018-2023)

3.2 Global Biopharmaceutical Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing Revenue

3.4 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio

3.4.1 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing Revenue in 2022

3.5 Biopharmaceutical Contract Manufacturing Key Players Head office and Area Served

3.6 Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service

3.7 Date of Enter into Biopharmaceutical Contract Manufacturing Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Type (2018-2023)

4.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2024-2029)

5.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Application (2018-2023)

5.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2024-2029)

6.1 North America Biopharmaceutical Contract Manufacturing Market Size (2018-2029)

6.2 North America Biopharmaceutical Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2018-2023)

6.4 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Biopharmaceutical Contract Manufacturing Market Size (2018-2029)

7.2 Europe Biopharmaceutical Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2018-2023)

7.4 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size (2018-2029)

8.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2018-2023)

8.4 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Biopharmaceutical Contract Manufacturing Market Size (2018-2029)

9.2 Latin America Biopharmaceutical Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2018-2023)

9.4 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size (2018-2029)

10.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2018-2023)

10.4 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Lonza Group

11.1.1 Lonza Group Company Detail

11.1.2 Lonza Group Business Overview

11.1.3 Lonza Group Biopharmaceutical Contract Manufacturing Introduction

11.1.4 Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)

11.1.5 Lonza Group Recent Development

11.2 Baxter Biopharma Solutions

11.2.1 Baxter Biopharma Solutions Company Detail

11.2.2 Baxter Biopharma Solutions Business Overview

11.2.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Introduction

11.2.4 Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)

11.2.5 Baxter Biopharma Solutions Recent Development

11.3 Samsung

11.3.1 Samsung Company Detail

11.3.2 Samsung Business Overview

11.3.3 Samsung Biopharmaceutical Contract Manufacturing Introduction

11.3.4 Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)

11.3.5 Samsung Recent Development

11.4 Fujifilm Diosynth Biotechnologies

11.4.1 Fujifilm Diosynth Biotechnologies Company Detail

11.4.2 Fujifilm Diosynth Biotechnologies Business Overview

11.4.3 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Introduction

11.4.4 Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)

11.4.5 Fujifilm Diosynth Biotechnologies Recent Development

11.5 Boehringer Ingelheim

11.5.1 Boehringer Ingelheim Company Detail

11.5.2 Boehringer Ingelheim Business Overview

11.5.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Introduction

11.5.4 Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)

11.5.5 Boehringer Ingelheim Recent Development

11.6 Patheon

11.6.1 Patheon Company Detail

11.6.2 Patheon Business Overview

11.6.3 Patheon Biopharmaceutical Contract Manufacturing Introduction

11.6.4 Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)

11.6.5 Patheon Recent Development

11.7 Rentschler Biotechnologie

11.7.1 Rentschler Biotechnologie Company Detail

11.7.2 Rentschler Biotechnologie Business Overview

11.7.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Introduction

11.7.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)

11.7.5 Rentschler Biotechnologie Recent Development

11.8 Biomeva

11.8.1 Biomeva Company Detail

11.8.2 Biomeva Business Overview

11.8.3 Biomeva Biopharmaceutical Contract Manufacturing Introduction

11.8.4 Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)

11.8.5 Biomeva Recent Development

11.9 Probiogen

11.9.1 Probiogen Company Detail

11.9.2 Probiogen Business Overview

11.9.3 Probiogen Biopharmaceutical Contract Manufacturing Introduction

11.9.4 Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)

11.9.5 Probiogen Recent Development

11.10 Cytovance Biologics

11.10.1 Cytovance Biologics Company Detail

11.10.2 Cytovance Biologics Business Overview

11.10.3 Cytovance Biologics Biopharmaceutical Contract Manufacturing Introduction

11.10.4 Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)

11.10.5 Cytovance Biologics Recent Development

11.11 KBI Biopharma

11.11.1 KBI Biopharma Company Detail

11.11.2 KBI Biopharma Business Overview

11.11.3 KBI Biopharma Biopharmaceutical Contract Manufacturing Introduction

11.11.4 KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)

11.11.5 KBI Biopharma Recent Development

11.12 WuXi Biologics

11.12.1 WuXi Biologics Company Detail

11.12.2 WuXi Biologics Business Overview

11.12.3 WuXi Biologics Biopharmaceutical Contract Manufacturing Introduction

11.12.4 WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)

11.12.5 WuXi Biologics Recent Development

11.13 Abzena

11.13.1 Abzena Company Detail

11.13.2 Abzena Business Overview

11.13.3 Abzena Biopharmaceutical Contract Manufacturing Introduction

11.13.4 Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)

11.13.5 Abzena Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Growth Factors

    Table 3. Key Players of Interferons

    Table 4. Key Players of Monoclonal Antibodies

    Table 5. Key Players of Recombinant Hormones

    Table 6. Key Players of Vaccines

    Table 7. Key Players of Insulin

    Table 8. Key Players of Others

    Table 9. Global Biopharmaceutical Contract Manufacturing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 10. Global Biopharmaceutical Contract Manufacturing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 11. Global Biopharmaceutical Contract Manufacturing Market Size by Region (2018-2023) & (US$ Million)

    Table 12. Global Biopharmaceutical Contract Manufacturing Market Share by Region (2018-2023)

    Table 13. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 14. Global Biopharmaceutical Contract Manufacturing Market Share by Region (2024-2029)

    Table 15. Biopharmaceutical Contract Manufacturing Market Trends

    Table 16. Biopharmaceutical Contract Manufacturing Market Drivers

    Table 17. Biopharmaceutical Contract Manufacturing Market Challenges

    Table 18. Biopharmaceutical Contract Manufacturing Market Restraints

    Table 19. Global Biopharmaceutical Contract Manufacturing Revenue by Players (2018-2023) & (US$ Million)

    Table 20. Global Biopharmaceutical Contract Manufacturing Market Share by Players (2018-2023)

    Table 21. Global Top Biopharmaceutical Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Contract Manufacturing as of 2022)

    Table 22. Ranking of Global Top Biopharmaceutical Contract Manufacturing Companies by Revenue (US$ Million) in 2022

    Table 23. Global 5 Largest Players Market Share by Biopharmaceutical Contract Manufacturing Revenue (CR5 and HHI) & (2018-2023)

    Table 24. Key Players Headquarters and Area Served

    Table 25. Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service

    Table 26. Date of Enter into Biopharmaceutical Contract Manufacturing Market

    Table 27. Mergers & Acquisitions, Expansion Plans

    Table 28. Global Biopharmaceutical Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million)

    Table 29. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type (2018-2023)

    Table 30. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 31. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type (2024-2029)

    Table 32. Global Biopharmaceutical Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million)

    Table 33. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Application (2018-2023)

    Table 34. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 35. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Application (2024-2029)

    Table 36. North America Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. North America Biopharmaceutical Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million)

    Table 38. North America Biopharmaceutical Contract Manufacturing Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Europe Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million)

    Table 41. Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2024-2029) & (US$ Million)

    Table 42. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2018-2023) & (US$ Million)

    Table 44. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2024-2029) & (US$ Million)

    Table 45. Latin America Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 49. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million)

    Table 50. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2024-2029) & (US$ Million)

    Table 51. Lonza Group Company Detail

    Table 52. Lonza Group Business Overview

    Table 53. Lonza Group Biopharmaceutical Contract Manufacturing Product

    Table 54. Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023) & (US$ Million)

    Table 55. Lonza Group Recent Development

    Table 56. Baxter Biopharma Solutions Company Detail

    Table 57. Baxter Biopharma Solutions Business Overview

    Table 58. Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Product

    Table 59. Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023) & (US$ Million)

    Table 60. Baxter Biopharma Solutions Recent Development

    Table 61. Samsung Company Detail

    Table 62. Samsung Business Overview

    Table 63. Samsung Biopharmaceutical Contract Manufacturing Product

    Table 64. Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023) & (US$ Million)

    Table 65. Samsung Recent Development

    Table 66. Fujifilm Diosynth Biotechnologies Company Detail

    Table 67. Fujifilm Diosynth Biotechnologies Business Overview

    Table 68. Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Product

    Table 69. Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023) & (US$ Million)

    Table 70. Fujifilm Diosynth Biotechnologies Recent Development

    Table 71. Boehringer Ingelheim Company Detail

    Table 72. Boehringer Ingelheim Business Overview

    Table 73. Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Product

    Table 74. Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023) & (US$ Million)

    Table 75. Boehringer Ingelheim Recent Development

    Table 76. Patheon Company Detail

    Table 77. Patheon Business Overview

    Table 78. Patheon Biopharmaceutical Contract Manufacturing Product

    Table 79. Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023) & (US$ Million)

    Table 80. Patheon Recent Development

    Table 81. Rentschler Biotechnologie Company Detail

    Table 82. Rentschler Biotechnologie Business Overview

    Table 83. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Product

    Table 84. Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023) & (US$ Million)

    Table 85. Rentschler Biotechnologie Recent Development

    Table 86. Biomeva Company Detail

    Table 87. Biomeva Business Overview

    Table 88. Biomeva Biopharmaceutical Contract Manufacturing Product

    Table 89. Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023) & (US$ Million)

    Table 90. Biomeva Recent Development

    Table 91. Probiogen Company Detail

    Table 92. Probiogen Business Overview

    Table 93. Probiogen Biopharmaceutical Contract Manufacturing Product

    Table 94. Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023) & (US$ Million)

    Table 95. Probiogen Recent Development

    Table 96. Cytovance Biologics Company Detail

    Table 97. Cytovance Biologics Business Overview

    Table 98. Cytovance Biologics Biopharmaceutical Contract Manufacturing Product

    Table 99. Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023) & (US$ Million)

    Table 100. Cytovance Biologics Recent Development

    Table 101. KBI Biopharma Company Detail

    Table 102. KBI Biopharma Business Overview

    Table 103. KBI Biopharma Biopharmaceutical Contract Manufacturing Product

    Table 104. KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023) & (US$ Million)

    Table 105. KBI Biopharma Recent Development

    Table 106. WuXi Biologics Company Detail

    Table 107. WuXi Biologics Business Overview

    Table 108. WuXi Biologics Biopharmaceutical Contract Manufacturing Product

    Table 109. WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023) & (US$ Million)

    Table 110. WuXi Biologics Recent Development

    Table 111. Abzena Company Detail

    Table 112. Abzena Business Overview

    Table 113. Abzena Biopharmaceutical Contract Manufacturing Product

    Table 114. Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023) & (US$ Million)

    Table 115. Abzena Recent Development

    Table 116. Research Programs/Design for This Report

    Table 117. Key Data Information from Secondary Sources

    Table 118. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Biopharmaceutical Contract Manufacturing Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Biopharmaceutical Contract Manufacturing Market Share by Type: 2022 VS 2029

    Figure 3. Growth Factors Features

    Figure 4. Interferons Features

    Figure 5. Monoclonal Antibodies Features

    Figure 6. Recombinant Hormones Features

    Figure 7. Vaccines Features

    Figure 8. Insulin Features

    Figure 9. Others Features

    Figure 10. Global Biopharmaceutical Contract Manufacturing Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 11. Global Biopharmaceutical Contract Manufacturing Market Share by Application: 2022 VS 2029

    Figure 12. Autoimmune Diseases Case Studies

    Figure 13. Oncology Case Studies

    Figure 14. Metabolic Diseases Case Studies

    Figure 15. Ophthalmology Case Studies

    Figure 16. Cardiovascular Diseases Case Studies

    Figure 17. Infectious Diseases Case Studies

    Figure 18. Neurology Case Studies

    Figure 19. Respiratory Disorders Case Studies

    Figure 20. Others Case Studies

    Figure 21. Biopharmaceutical Contract Manufacturing Report Years Considered

    Figure 22. Global Biopharmaceutical Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 23. Global Biopharmaceutical Contract Manufacturing Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 24. Global Biopharmaceutical Contract Manufacturing Market Share by Region: 2022 VS 2029

    Figure 25. Global Biopharmaceutical Contract Manufacturing Market Share by Players in 2022

    Figure 26. Global Top Biopharmaceutical Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Contract Manufacturing as of 2022)

    Figure 27. The Top 10 and 5 Players Market Share by Biopharmaceutical Contract Manufacturing Revenue in 2022

    Figure 28. North America Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. North America Biopharmaceutical Contract Manufacturing Market Share by Country (2018-2029)

    Figure 30. United States Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Canada Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Europe Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Europe Biopharmaceutical Contract Manufacturing Market Share by Country (2018-2029)

    Figure 34. Germany Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. France Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. U.K. Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Italy Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Russia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Nordic Countries Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Share by Region (2018-2029)

    Figure 42. China Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Japan Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. South Korea Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Southeast Asia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. India Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Australia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Latin America Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Latin America Biopharmaceutical Contract Manufacturing Market Share by Country (2018-2029)

    Figure 50. Mexico Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 51. Brazil Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 52. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 53. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Share by Country (2018-2029)

    Figure 54. Turkey Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 55. Saudi Arabia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 56. Lonza Group Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2018-2023)

    Figure 57. Baxter Biopharma Solutions Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2018-2023)

    Figure 58. Samsung Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2018-2023)

    Figure 59. Fujifilm Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2018-2023)

    Figure 60. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2018-2023)

    Figure 61. Patheon Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2018-2023)

    Figure 62. Rentschler Biotechnologie Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2018-2023)

    Figure 63. Biomeva Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2018-2023)

    Figure 64. Probiogen Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2018-2023)

    Figure 65. Cytovance Biologics Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2018-2023)

    Figure 66. KBI Biopharma Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2018-2023)

    Figure 67. WuXi Biologics Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2018-2023)

    Figure 68. Abzena Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2018-2023)

    Figure 69. Bottom-up and Top-down Approaches for This Report

    Figure 70. Data Triangulation

    Figure 71. Key Executives Interviewed